Skip to content

Drug interactions

Ivosidenib + Solifenacin

Severity: Major

Ivosidenib and Solifenacin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivosidenib prolongs the QT interval, and solifenacin may add to this. Ivosidenib is also a CYP3A4 inducer, which could lower solifenacin exposure and reduce its efficacy.

What this interaction means in plain words

Ivosidenib and Solifenacin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ivosidenib belongs to Oncology; Solifenacin belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Additive QT prolongation, plus induction of CYP3A4 by ivosidenib that lowers solifenacin levels.

What to do

Avoid the combination if possible. If both are used, monitor ECG and electrolytes and assess whether solifenacin is still effective.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ivosidenib and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ivosidenib with Solifenacin?

MediHelp rates the interaction as major. Ivosidenib and Solifenacin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ivosidenib prolongs the QT interval, and solifenacin may add to this. Ivosidenib is also a CYP3A4 inducer, which could lower solifenacin exposure and reduce its efficacy.

How serious is the interaction between Ivosidenib and Solifenacin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If both are used, monitor ECG and electrolytes and assess whether solifenacin is still effective.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in